Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bay City Capital Fund Iv, L.p.


  • Large Shareholder, Director at Synta Pharmaceuticals Corp (MDGL), 2016-07-26
  • Other at Nevro Corp (NVRO), 2015-06-18
  • Large Shareholder at Enteromedics Inc (ETRM), 2011-09-26
  • Large Shareholder at Via Pharmaceuticals Inc. (VIAP), 2010-11-16
  • Large Shareholder at Map Pharmaceuticals Inc. (MAPP), 2010-03-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MAPP $16.06 54,300 Large Shareholder 2,007,163 2010-03-11 Filing
MAPP $16.03 134,190 Large Shareholder 2,061,463 2010-03-10 Filing
MAPP $15.50 151,424 Large Shareholder 2,195,653 2010-03-09 Filing